Karsten Knudsen | Chief Financial Officer |
Martin Holst Lange | EVP and Head of Development |
Mads Frederik Rasmussen | Senior Vice President and Head of Clinical Drug Development |
Michael Novod | Nordea Markets |
Richard Vosser | JPMorgan Chase & Co |
Mark Purcell | Morgan Stanley |
Michael Nedelcovych | Cowen and Company |
Jesper Ilsoe | Carnegie |
Welcome to the Novo Nordisk R&D event in conjunction with the ADA 2022 here in New Orleans in hot summer June. It's great to see all here, and we have a very nice R&D presentation coming up. And I have to remind you that this event is being broadcasted. And the setup is that we will do a presentation of some 40 minutes or something like that, followed by a Q&A. And then we have a small social event afterwards.